← Product Code [GEX](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX) · K083848 # ALMA LASERS SOPRANO XL MULTI-APPLICATION PLATFORM (K083848) _Alma Lasers , Ltd. · GEX · Apr 14, 2009 · General, Plastic Surgery · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K083848 ## Device Facts - **Applicant:** Alma Lasers , Ltd. - **Product Code:** [GEX](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX.md) - **Decision Date:** Apr 14, 2009 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 878.4810 - **Device Class:** Class 2 - **Review Panel:** General, Plastic Surgery - **Attributes:** Therapeutic ## Intended Use The SOPRANO XL™ Multi-Application Platform includes a Diode Laser Module and an optional NIR Module. The Diode Laser Module: The HR Mode is intended for hair removal, permanent hair reduction. The LaserBlanche Mode is intended for the treatment of benign vascular and pigmented lesions. The NIR Module is intended to emit energy in the infrared spectrum to provide topical heating for the purpose of elevating the tissue temperature for the temporary relief of minor muscle pain and joint pain and stiffness, the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and the relaxation of muscles; may also help muscle spasms, minor sprains and strains, and minor muscular back pain. The SOPRANO XL™ Multi-Application Platform is intended for use on all skin types (Fitzpatrick skin types I-VI), including tanned skin. ## Device Story Soprano XL is a multi-application platform consisting of a console, diode laser module, and footswitch. Device delivers laser energy to patient skin via a contact-cooled module tip. Clinician operates system via touch-screen control panel to select modes (HR for hair removal; LaserBlanche for vascular/pigmented lesions). System micro-controller manages output parameters. Used in clinical settings by trained professionals. Benefits include permanent hair reduction and treatment of benign skin lesions across all skin types. ## Clinical Evidence No clinical data provided; substantial equivalence based on technological characteristics and comparison to legally marketed predicate devices. ## Technological Characteristics Multi-application platform supporting diode laser and NIR light technologies. Features console with LCD touch-screen interface, micro-controller, and contact-cooled diode module. Energy source: diode laser. Form factor: floor-standing console with handheld applicator. Connectivity: standalone system. ## Regulatory Identification (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon. ## Predicate Devices - LightSheer Pulsed Diode Array Laser System ([K001746](/device/K001746.md)) - LightSheer Pulsed Diode Array Laser System ([K003614](/device/K003614.md)) - Palomar SLP™ 1000 ([K013028](/device/K013028.md)) - MeDioStar XL ([K050900](/device/K050900.md)) - Soprano Hair Removal Diode Laser System ([K052874](/device/K052874.md)) - LightSheer Duet™ Laser System ([K053628](/device/K053628.md)) ## Reference Devices - Soprano XL NIR Module ([K080318](/device/K080318.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ 16083848♡ # . APR 1 4 2009 ### Section 5 - 510(k) Summary or 510(k) Statement #### I. General Information Submitter: Alma Lasers, Ltd. Halamish Street (PO Box 3021), Industrial Park, Caesarea, 38900 ISRAEL | Contact Person: | Tatiana Epstein
Regulatory Affairs Manager,
Alma Lasers, Ltd. | |-----------------|---------------------------------------------------------------------| |-----------------|---------------------------------------------------------------------| December 20th, 2008 Summary Preparation Date: - II. Names Device Names: Alma Lasers Soprano XL Multi-Application Platform Primary Classification Names: Laser Instrument, Surgical, Powered #### III. Predicate Devices - · K001746 LightSheer Pulsed Diode Array Laser System Lumenis, Inc. (formerly Coherent Star) - · K003614 LightSheer Pulsed Diode Array Laser System Lumenis, Inc. (formerly Coherent Star) - · K013028 Palomar SLP™ 1000 -- Palomar Medical Technologies, Inc. - · K050900 MeDioStar XL Asclepion Laser technologies, GmbH. - · K052874 · Soprano Hair Removal Diode Laser System Alma Lasers, Ltd. (formerly MSq., Ltd.) - · K053628 LightSheer Duet™ Laser System Lumenis, Inc. #### IV. Product Description The Soprano XL Multi-Application Platform features an additional indication for the treatment of benign vascular and pigmented lesions introduced to its Diode Module compared to the existing Alma Lasers, Ltd. (former MSq., Ltd.) Soprano Diode Laser System, previously cleared under K052874 for hair removal and long-term hair reduction. The Soprano XL system is indicated for use on all skin types (Fitzpatrick Skin Types I-VI), including tanned skin. The Soprano XL Multi-Application Platform is a multi-application, multi-technology platform that supports the following technologies: - · Diode laser technology - · Near-infrared light technology (NIR)2. Premarket Notification, 510(k) Submission for: Alma Lasers Soprano XL Multi-Application Platform Section 5: 510(k) Summary - Page 1 2 The Soprano XL NIR Module is cleared separately under K080318. {1}------------------------------------------------ Both the Soprano and Soprano XL systems consist of a console, a diode module and a footswitch. The module is pressed against the patient skin and a laser pulse is delivered when the module trigger and the footswitch are activated. The module tip is cooled by the cooling system. Output parameters and other system features are controlled from the touch-screen control panel on the console, which provides an interface to the system micro-controller through an LCD touch-screen. #### V. Indications for Use The SOPRANO XL™ Multi-Application Platform includes a Diode Laser Module and an optional NIR Module. The Diode Laser Module: The HR Mode is intended for hair removal, permanent hair reduction. The LaserBlanche Mode is intended for the treatment of benign vascular and pigmented lesions. The NIR Module is intended to emit energy in the infrared spectrum to provide topical heating for the purpose of elevating the tissue temperature for the temporary relief of minor muscle pain and joint pain and stiffness, the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and the relaxation of muscles; may also help muscle spasms, minor sprains and strains, and minor muscular back pain. The SOPRANO XL™ Multi-Application Platform is intended for use on all skin types (Fitzpatrick skin types I-VI), including tanned skin. #### VI. Rationale for Substantial Equivalence The Alma Lasers Soprano XL Multi-Application Platform shares the same indications for use, the operation, technical and functional capabilities, and therefore is substantially equivalent to the predicate devices. #### VII. Safety and Effectiveness Information The review of the indications for use and technical characteristics provided demonstrates that the Alma Lasers Soprano XL Multi-Application Platform is substantially equivalent . to the predicate devices. #### VIII. Conclusion The Alma Lasers Soprano XL Multi-Application Platform was found to be substantially equivalent to the predicate devices. The Alma Lasers Soprano XL Multi-Application Platform shares the same or similar indications for use, similar design features, and functional features with, and thus is substantially equivalent to the predicate devices. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized eagle emblem, with three curved lines representing the eagle's wings and body. ### Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ## APR 1 4 2009 Alma Lasers, Ltd. % Ms. Tatiana Epstein RA Manager Halamish Street, P.O. Box 3021 Industrial Park Caesarea 38900 Israel Re: K083848 Trade/Device Name: Alma Lasers Soprano XL™ Multi-Application Platform Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: March 24, 2009 Received: March 26, 2009 Dear Ms. Epstein: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must {3}------------------------------------------------ Page 2 - Ms. Tatiana Epstein comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliaring at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities inder the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Mark A. Millhuss Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ ### Indications for Use Statement 510(k) Number (if known): K083848 Device Name: Alma Lasers Soprano XLTM Multi-Application Platform Indications for Use: The SOPRANO XLTM Multi-Application Platform includes a Diode Laser Module and an optional NIR Module. The Diode Laser Module: The HR Mode is intended for hair removal, permanent hair reduction. The LaserBlanche Mode is intended for the treatment of benign vascular and pigmented lesions. The NIR Module is intended to emit energy in the infrared spectrum to provide topical heating for the purpose of elevating the tissue temperature for the temporary relief of minor muscle pain and joint pain and stiffness, the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and the relaxation of muscles; may also help muscle spasms, minor sprains and strains, and minor muscular back pain. The SOPRANO XL™ Multi-Application Platform is intended for use on all skin types (Fitzpatrick skin types I-VI), including tanned skin. Prescription Use (Part 21 CFR 801 Subpart D) 510(k) Number AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) for mkm (Division Fgn-Off) Division of General, Restorative, and Neurological Devices K083848 15 --- **Source:** [https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K083848](https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K083848) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com